Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Cytomegalovirus Infections × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Breast Neoplasms 52 Neoplasms 49 Colorectal Neoplasms 24 Prostatic Neoplasms 21 Lung Neoplasms 21 Neoplastic Cells, Circulating 17 Carcinoma, Non-Small-Cell Lung 17 Pancreatic Neoplasms 16 Head and Neck Neoplasms 16 Melanoma 14 Ovarian Neoplasms 11 Esophageal Neoplasms 10 Colonic Neoplasms 10 Carcinoma, Hepatocellular 10 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Glioma 8 Squamous Cell Carcinoma of Head and Neck 7 Neoplasm Metastasis 7 Multiple Myeloma 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7 Neoplasm, Residual 6 Myeloproliferative Disorders 6 Kidney Neoplasms 6 Carcinoma, Renal Cell 6 Adenocarcinoma 6 Stomach Neoplasms 5 Sarcoma 5 Obesity 5

Interventions

Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Magnetic Resonance Spectroscopy 1 Gene-Eden-VIR 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Blood Specimen Collection 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02600065 2023-02-16

GLIO-CMV-01

University of Erlangen-Nürnberg Medical School

Cytomegalovirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡